Belimumab Treatment for IgG4-related Disease

NCT04660565 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

IgG4-related Disease

Interventions

DRUG: Prednisone and Belimumab
DRUG: Prednisone

Sponsor

Peking Union Medical College Hospital